Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology - 1 Jul 2004

Lu Wei-Lun, Xie Dong-Ying, Yao Ji-Lu, Yao Guang-Bi, Cui Zhen-Yu, Zhang Ding-Feng, Wu Lei

Abstract excerpt

OBJECTIVE: To analysis the efficacy and safety of lamivudine (made in China) therapy for 52 weeks in adolescent patients with chronic hepatitis B (CHB). METHODS: One hundred and five teenage CHB patients were treated with lamivudine 100 mg once daily for 52 weeks. Patients with elevated ALT at baseline were in group 1 and those with normal ALT were in group 2. The changes of HBV DNA, HBV seromarkers and ALT at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Hepatitis B Antibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Interferons

Share to Lamivudine

Share to Reverse Transcriptase Inhibitors

Share to Safety

Source

Identifiers

PMID: 15268810

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy].PMID 15268810Read ↗

[Clinical efficacy of lamivudine in the treatment of chronic hepatitis B].Semantic proximity Read ↗

[Lamivudine treatment for hepatitis B].Semantic proximity Read ↗

[Lamivudine therapy for chronic hepatitis B].Semantic proximity Read ↗

[Relationship between B virus hepatitis genotypes and therapeutic efficacy in early treatment for chronic hepatitis B by using lamivudine].Semantic proximity Read ↗

[Treatment of chronic viral hepatitis B with lamivudine].Semantic proximity Read ↗

A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naïve Chronic Hepatitis B.Semantic proximity Read ↗

Entecavir treatment of children 2-16 years of age with chronic hepatitis B infection.Semantic proximity Read ↗

Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients.Semantic proximity Read ↗

Management of hepatitis B in China.Semantic proximity Read ↗

[Evaluation of Chai Shao Liu Jun Tang for the treatment of chronic hepatitis B].Semantic proximity Read ↗

[The mutation patterns of HBV P gene and genotyping in patients with lanivudine-resistant chronic hepatitis B].Semantic proximity Read ↗

[Observation on effect of peg interferon lphaa-2a treating lamivudine resistant chronic hepatitis B].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.